ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVTA

Invitae (NVTA)

Invitae Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVTA
DateTimeSourceHeadlineSymbolCompany
02/06/20245:07PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
01/30/20247:00AMPR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
01/29/20244:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
01/24/20244:34PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
01/22/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
01/22/20247:00AMPR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
01/18/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
12/21/20239:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
12/21/20239:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
12/14/20234:29PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
12/13/20234:07PMPR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
12/11/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/17/20234:48PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/15/20234:22PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/14/20237:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
11/14/20237:55PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
11/08/20234:36PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
11/08/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
11/08/20234:01PMPR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
11/06/20234:00PMPR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
11/01/20236:59AMPR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
10/25/202311:00AMPR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
10/20/20236:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
10/19/20234:38PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
10/19/20234:30PMPR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
10/12/20234:15PMPR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
10/10/20234:30PMPR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
10/03/202312:07PMPR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
10/02/20239:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
10/02/20238:47PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com